SE9803240D0
(sv)
|
1998-09-24 |
1998-09-24 |
Diabact Ab |
A pharmaceutical composition having a rapid action
|
EP1005863A1
(de)
*
|
1998-12-04 |
2000-06-07 |
Synthelabo |
Dosisformen mit gesteuerter Wirkstofffreigabe enthaltend ein kurzer wirkung Hypnotikum oder einem Salz davon
|
US20040258750A1
(en)
*
|
1999-06-28 |
2004-12-23 |
Gerard Alaux |
Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
|
EP2269587A1
(de)
|
1999-10-29 |
2011-01-05 |
Euro-Celtique S.A. |
Hydrocodon-Formulierungen mit gesteuerter Freisetzung
|
US10179130B2
(en)
|
1999-10-29 |
2019-01-15 |
Purdue Pharma L.P. |
Controlled release hydrocodone formulations
|
AU5066101A
(en)
*
|
2000-04-13 |
2001-10-30 |
Synthon B.V. |
Modified release formulations containing a hypnotic agent
|
AU2738302A
(en)
|
2000-10-30 |
2002-05-15 |
Euro Celtique Sa |
Controlled release hydrocodone formulations
|
US20030070584A1
(en)
|
2001-05-15 |
2003-04-17 |
Cynthia Gulian |
Dip coating compositions containing cellulose ethers
|
US7458374B2
(en)
|
2002-05-13 |
2008-12-02 |
Alexza Pharmaceuticals, Inc. |
Method and apparatus for vaporizing a compound
|
US7766013B2
(en)
|
2001-06-05 |
2010-08-03 |
Alexza Pharmaceuticals, Inc. |
Aerosol generating method and device
|
US7645442B2
(en)
|
2001-05-24 |
2010-01-12 |
Alexza Pharmaceuticals, Inc. |
Rapid-heating drug delivery article and method of use
|
CA2452874A1
(en)
*
|
2001-07-06 |
2003-01-16 |
Endo Pharmaceuticals, Inc. |
Oral administration of 6-hydroxy-oxymorphone for use as an analgesic
|
PL207748B1
(pl)
*
|
2001-07-06 |
2011-01-31 |
Penwest Pharmaceuticals Company |
Preparat o przedłużonym uwalnianiu zawierający oksymorfon oraz jego zastosowanie
|
US8329216B2
(en)
|
2001-07-06 |
2012-12-11 |
Endo Pharmaceuticals Inc. |
Oxymorphone controlled release formulations
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
US7332182B2
(en)
|
2001-08-06 |
2008-02-19 |
Purdue Pharma L.P. |
Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant
|
US7842307B2
(en)
|
2001-08-06 |
2010-11-30 |
Purdue Pharma L.P. |
Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent
|
US20030068276A1
(en)
|
2001-09-17 |
2003-04-10 |
Lyn Hughes |
Dosage forms
|
FR2829933B3
(fr)
*
|
2001-09-21 |
2004-03-12 |
Ellipse Pharmaceuticals |
Procede de fabrication d'un produit pharmaceutique administrable par voie orale avec des agents detrompeurs notamment de gout et produit obtenu
|
US8309118B2
(en)
|
2001-09-28 |
2012-11-13 |
Mcneil-Ppc, Inc. |
Film forming compositions containing sucralose
|
US8101209B2
(en)
|
2001-10-09 |
2012-01-24 |
Flamel Technologies |
Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
|
IL164221A0
(en)
|
2002-04-09 |
2005-12-18 |
Flamel Tech Sa |
Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillim
|
IL164222A0
(en)
|
2002-04-09 |
2005-12-18 |
Flamel Tech Sa |
Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)
|
DE10250083A1
(de)
*
|
2002-06-17 |
2003-12-24 |
Gruenenthal Gmbh |
Gegen Missbrauch gesicherte Darreichungsform
|
US7776314B2
(en)
*
|
2002-06-17 |
2010-08-17 |
Grunenthal Gmbh |
Abuse-proofed dosage system
|
CA2491572C
(en)
*
|
2002-07-05 |
2010-03-23 |
Collegium Pharmaceutical, Inc. |
Abuse-deterrent pharmaceutical compositions of opiods and other drugs
|
US8840928B2
(en)
*
|
2002-07-05 |
2014-09-23 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
US8557291B2
(en)
|
2002-07-05 |
2013-10-15 |
Collegium Pharmaceutical, Inc. |
Abuse-deterrent pharmaceutical compositions of opioids and other drugs
|
US10004729B2
(en)
|
2002-07-05 |
2018-06-26 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
CA2499994C
(en)
*
|
2002-09-23 |
2012-07-10 |
Verion, Inc. |
Abuse-resistant pharmaceutical compositions
|
DE10250084A1
(de)
*
|
2002-10-25 |
2004-05-06 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
US7913688B2
(en)
|
2002-11-27 |
2011-03-29 |
Alexza Pharmaceuticals, Inc. |
Inhalation device for producing a drug aerosol
|
CA2523367A1
(en)
*
|
2003-05-02 |
2004-11-11 |
Warner-Lambert Company Llc |
Confectionery products for delivery of pharmaceutically active agents to the throat
|
ATE344659T1
(de)
*
|
2003-05-02 |
2006-11-15 |
Dexcel Ltd |
Tablettenzubereitung mit verlängerter freisetzung von venlafaxin
|
US8075872B2
(en)
|
2003-08-06 |
2011-12-13 |
Gruenenthal Gmbh |
Abuse-proofed dosage form
|
DE10361596A1
(de)
*
|
2003-12-24 |
2005-09-29 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
DE10336400A1
(de)
*
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
US20070048228A1
(en)
|
2003-08-06 |
2007-03-01 |
Elisabeth Arkenau-Maric |
Abuse-proofed dosage form
|
DE102005005446A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Bruchfeste Darreichungsformen mit retardierter Freisetzung
|
DE102004032051A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
DE102004020220A1
(de)
*
|
2004-04-22 |
2005-11-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
US7201920B2
(en)
|
2003-11-26 |
2007-04-10 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of opioid containing dosage forms
|
EP1703932A1
(de)
*
|
2003-12-15 |
2006-09-27 |
Alexza Molecular Delivery Corporation |
Behandlung von durchbruchsschmerzen durch medikamentenaerosolinhalation
|
US20050165038A1
(en)
†
|
2004-01-22 |
2005-07-28 |
Maxwell Gordon |
Analgetic dosage forms that are resistant to parenteral and inhalation dosing and have reduced side effects
|
KR20140104986A
(ko)
*
|
2004-02-17 |
2014-08-29 |
트랜스셉트 파마슈티칼스, 인코포레이티드 |
구강 점막을 가로지르는 수면제 전달용 조성물 및 이의 사용 방법
|
WO2005102286A1
(de)
*
|
2004-04-22 |
2005-11-03 |
Grünenthal GmbH |
Verfahren zur herstellung einer gegen missbrauch gesicherten, festen darreinchungsform
|
CA2564960A1
(en)
*
|
2004-05-21 |
2005-12-01 |
Lawrence Solomon |
Pharmaceutical tablets having a separation mark positioned on the side of said tablets
|
US7329418B2
(en)
*
|
2004-05-21 |
2008-02-12 |
Accu Break Technologies, Inc. |
Pharmaceutical tablets having height greater than width
|
US7713547B2
(en)
|
2004-05-21 |
2010-05-11 |
Accu-Break Pharmaceuticals, Inc. |
Method of administering a partial dose of a segmented pharmaceutical tablet
|
US7838031B2
(en)
|
2004-05-21 |
2010-11-23 |
Lawrence Solomon |
Method of administering a partial dose using a segmented pharmaceutical tablet
|
US7622137B2
(en)
*
|
2004-05-21 |
2009-11-24 |
Accu-Break Technologies, Inc. |
Dosage forms contained within a capsule or sachet
|
US7318935B2
(en)
*
|
2004-05-21 |
2008-01-15 |
Accu-Break Technologies, Inc. |
Pharmaceutical tablets with active and inactive segments
|
US7780985B2
(en)
*
|
2005-07-12 |
2010-08-24 |
Accu-Break Technologies, Inc. |
Tablets having a printed separation mark to guide breaking
|
US8216610B2
(en)
*
|
2004-05-28 |
2012-07-10 |
Imaginot Pty Ltd. |
Oral paracetamol formulations
|
JP2008500288A
(ja)
*
|
2004-05-28 |
2008-01-10 |
イメイジノット ピーティーワイ エルティーディー |
経口治療用化合物の供給系
|
US7540286B2
(en)
|
2004-06-03 |
2009-06-02 |
Alexza Pharmaceuticals, Inc. |
Multiple dose condensation aerosol devices and methods of forming condensation aerosols
|
EP3326617A1
(de)
|
2004-06-12 |
2018-05-30 |
Collegium Pharmaceutical, Inc. |
Missbrauchsverhindernde arzneimittelformulierungen
|
ITMI20041317A1
(it)
*
|
2004-06-30 |
2004-09-30 |
Ibsa Inst Biochimique Sa |
Formulazioni farmaceutiche per la somministrazione sicura di farmaci utilizzati nel trattamento della tossicodipendenza e procedimento per il loro ottenimento
|
DE102004032049A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
AU2005266459A1
(en)
*
|
2004-07-29 |
2006-02-02 |
Sanofi-Aventis |
Pharmaceutical multilayer tablet for controlled release of active ingredients with highly pH-dependent solubility
|
CA2575739A1
(en)
*
|
2004-08-06 |
2006-02-16 |
Grain Processing Corporation |
Tablet coating composition
|
FR2878161B1
(fr)
*
|
2004-11-23 |
2008-10-31 |
Flamel Technologies Sa |
Forme medicamenteuse orale, solide et concue pour eviter le mesusage
|
US20070231268A1
(en)
*
|
2004-11-24 |
2007-10-04 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
US20060177380A1
(en)
*
|
2004-11-24 |
2006-08-10 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
FR2878158B1
(fr)
*
|
2004-11-24 |
2009-01-16 |
Flamel Technologies Sa |
Forme pharmaceutique orale, microparticulaire solide concue pour eviter le mesusage
|
US20080152595A1
(en)
*
|
2004-11-24 |
2008-06-26 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
US20060110327A1
(en)
*
|
2004-11-24 |
2006-05-25 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
DE102005005449A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
FR2881652B1
(fr)
*
|
2005-02-08 |
2007-05-25 |
Flamel Technologies Sa |
Forme pharmaceutique orale microparticulaire anti-mesuage
|
GB0506982D0
(en)
*
|
2005-04-06 |
2005-05-11 |
Mw Encap Ltd |
Abuse resistant capsules
|
KR100714616B1
(ko)
*
|
2005-06-23 |
2007-05-07 |
삼성전기주식회사 |
지수 함수 발생기 및 이를 이용한 가변 이득 증폭기
|
US20090082466A1
(en)
*
|
2006-01-27 |
2009-03-26 |
Najib Babul |
Abuse Resistant and Extended Release Formulations and Method of Use Thereof
|
US20100210732A1
(en)
*
|
2005-11-02 |
2010-08-19 |
Najib Babul |
Methods of Preventing the Serotonin Syndrome and Compositions for Use Therefor
|
US9125833B2
(en)
*
|
2005-11-02 |
2015-09-08 |
Relmada Therapeutics, Inc. |
Multimodal abuse resistant and extended release opioid formulations
|
US8329744B2
(en)
*
|
2005-11-02 |
2012-12-11 |
Relmada Therapeutics, Inc. |
Methods of preventing the serotonin syndrome and compositions for use thereof
|
US8652529B2
(en)
|
2005-11-10 |
2014-02-18 |
Flamel Technologies |
Anti-misuse microparticulate oral pharmaceutical form
|
CA2629740A1
(en)
*
|
2005-11-18 |
2007-06-14 |
Synthon B.V. |
Zolpidem tablets
|
CN101351195A
(zh)
*
|
2005-11-18 |
2009-01-21 |
阿库布莱克科技公司 |
分段的药物剂量形式
|
EP3263117A1
(de)
|
2005-11-28 |
2018-01-03 |
Imaginot Pty Ltd. |
Abgabesystem für eine orale therapeutische verbindung
|
US8691272B2
(en)
*
|
2005-12-30 |
2014-04-08 |
Intelgenx Corp. |
Multilayer tablet
|
US20070264346A1
(en)
*
|
2006-02-16 |
2007-11-15 |
Flamel Technologies |
Multimicroparticulate pharmaceutical forms for oral administration
|
US20070237815A1
(en)
*
|
2006-04-06 |
2007-10-11 |
Lawrence Solomon |
Dosage forms and methods comprising amlodipine and chlorthalidone
|
JP4720620B2
(ja)
*
|
2006-05-30 |
2011-07-13 |
コニカミノルタビジネステクノロジーズ株式会社 |
カール補正装置及びこれを備えた画像形成装置
|
US20080069891A1
(en)
|
2006-09-15 |
2008-03-20 |
Cima Labs, Inc. |
Abuse resistant drug formulation
|
WO2008021875A2
(en)
*
|
2006-08-08 |
2008-02-21 |
Accu-Break Technologies, Inc. |
Pharmaceutical tablets containing a plurality of active segments
|
SA07280459B1
(ar)
|
2006-08-25 |
2011-07-20 |
بيورديو فارما إل. بي. |
أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
|
WO2008033351A2
(en)
*
|
2006-09-11 |
2008-03-20 |
Theraquest Biosciences, Inc. |
Multimodal abuse resistant and extended release formulations
|
US8445018B2
(en)
|
2006-09-15 |
2013-05-21 |
Cima Labs Inc. |
Abuse resistant drug formulation
|
US8187636B2
(en)
|
2006-09-25 |
2012-05-29 |
Atlantic Pharmaceuticals, Inc. |
Dosage forms for tamper prone therapeutic agents
|
US20100068271A1
(en)
*
|
2006-11-30 |
2010-03-18 |
Accu-Break Technologies, Inc |
Divisible Osmotic Dosage Forms and Methods of Use
|
US20080145425A1
(en)
*
|
2006-12-15 |
2008-06-19 |
Pliva Research & Development Limited |
Pharmaceutical composition of zolpidem
|
DE102007011485A1
(de)
|
2007-03-07 |
2008-09-11 |
Grünenthal GmbH |
Darreichungsform mit erschwertem Missbrauch
|
ES2594867T3
(es)
|
2007-03-09 |
2016-12-23 |
Alexza Pharmaceuticals, Inc. |
Unidad de calentamiento para usar en un dispositivo de administración de fármaco
|
WO2008150526A1
(en)
*
|
2007-06-04 |
2008-12-11 |
Shear/Kershman Laboratories, Inc. |
Tamper resistant lipid-based oral dosage form for opioid agonists
|
WO2008155620A1
(en)
*
|
2007-06-20 |
2008-12-24 |
Develco Pharma Schweiz Ag |
Dosage form containing dispersible matrix of sustained release granules
|
US20080318994A1
(en)
*
|
2007-06-21 |
2008-12-25 |
Endo Pharmaceuticals, Inc. |
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Renal Impairment
|
US20080318993A1
(en)
*
|
2007-06-21 |
2008-12-25 |
Endo Pharmaceuticals, Inc. |
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Hepatic Impairment
|
US20090004231A1
(en)
|
2007-06-30 |
2009-01-01 |
Popp Shane M |
Pharmaceutical dosage forms fabricated with nanomaterials for quality monitoring
|
CN101801350A
(zh)
|
2007-08-13 |
2010-08-11 |
阿巴斯迪特宁医药有限公司 |
抗滥用药物、使用方法和制备方法
|
AU2008338207A1
(en)
|
2007-12-17 |
2009-06-25 |
Labopharm (Barbados) Limited |
Misuse preventative, controlled release formulation
|
US8383152B2
(en)
|
2008-01-25 |
2013-02-26 |
Gruenenthal Gmbh |
Pharmaceutical dosage form
|
JP2011511782A
(ja)
|
2008-02-12 |
2011-04-14 |
アボット・ラボラトリーズ |
長期放出性ヒドロコドンアセトアミノフェンならびにその関連方法および用途
|
HUE030803T2
(en)
|
2008-05-09 |
2017-06-28 |
Gruenenthal Gmbh |
Process for the preparation of an intermediate powder formulation and a final solid dosage form using a spraying step \ t
|
US8420700B1
(en)
*
|
2008-06-04 |
2013-04-16 |
James M. Bausch |
Tamper resistant lipid-based oral dosage form for sympathomimetic amines
|
NZ592437A
(en)
|
2008-10-30 |
2013-03-28 |
Gruenenthal Chemie |
A dosage form comprising tapentadol and an opioid antagonist
|
ES2414856T3
(es)
*
|
2008-12-12 |
2013-07-23 |
Paladin Labs Inc. |
Formulaciones de fármaco narcótico con potencial de adicción disminuido
|
ES2509497T3
(es)
*
|
2008-12-16 |
2014-10-17 |
Paladin Labs Inc. |
Formulación de liberación controlada para evitar un uso indebido
|
EP3632417A1
(de)
*
|
2009-01-30 |
2020-04-08 |
Sunovion Pharmaceuticals Inc. |
Dragees mit 6-(5-chloro-2-pyridyl) -5-[ (4-methyl-1-piperazinyl) carbonyloxy]-7-oxo-6, 7-dihydro-5h-pyrrolo [3,4-b] pyrazin
|
RU2555531C2
(ru)
|
2009-07-22 |
2015-07-10 |
Грюненталь Гмбх |
Защищенная от применения не по назначению лекарственная форма для чувствительных к окислению опиоидов
|
KR101738369B1
(ko)
|
2009-07-22 |
2017-05-22 |
그뤼넨탈 게엠베하 |
핫 멜트 압출된 제어 방출 투여형
|
EP3064064A1
(de)
*
|
2009-09-30 |
2016-09-07 |
Acura Pharmaceuticals, Inc. |
Verfahren und zusammensetzungen zur abschreckung vor missbrauch
|
US20110136815A1
(en)
|
2009-12-08 |
2011-06-09 |
Horst Zerbe |
Solid oral film dosage forms and methods for making same
|
US10610528B2
(en)
|
2009-12-08 |
2020-04-07 |
Intelgenx Corp. |
Solid oral film dosage forms and methods for making same
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
US9579285B2
(en)
|
2010-02-03 |
2017-02-28 |
Gruenenthal Gmbh |
Preparation of a powdery pharmaceutical composition by means of an extruder
|
EA029077B1
(ru)
*
|
2010-03-09 |
2018-02-28 |
Алкермес Фарма Айэленд Лимитед |
Устойчивая к спирту фармацевтическая лекарственная форма
|
EP2568977A1
(de)
|
2010-05-11 |
2013-03-20 |
Cima Labs Inc. |
Alkoholresistente metoprololhaltige orale retard-dosierformen
|
AR082862A1
(es)
|
2010-09-02 |
2013-01-16 |
Gruenenthal Gmbh |
Forma de dosificacion resistente a alteracion que comprende un polimero anionico
|
EP2611426B1
(de)
|
2010-09-02 |
2014-06-25 |
Grünenthal GmbH |
Manipulationssichere darreichungsform mit einem anorganischen salz
|
EP2826468A1
(de)
|
2010-12-22 |
2015-01-21 |
Purdue Pharma L.P. |
Gekapselte manipulationssichere Darreichungsformen mit gesteuerter Freisetzung
|
CN103327969A
(zh)
|
2010-12-23 |
2013-09-25 |
普渡制药公司 |
抗篡改固体口服剂型
|
CA2837077A1
(en)
*
|
2011-06-01 |
2012-12-06 |
Fmc Corporation |
Controlled release solid dose forms
|
EA201400172A1
(ru)
|
2011-07-29 |
2014-06-30 |
Грюненталь Гмбх |
Устойчивая к разрушению таблетка, которая обеспечивает немедленное высвобождение лекарственного средства
|
AR087359A1
(es)
|
2011-07-29 |
2014-03-19 |
Gruenenthal Gmbh |
Tableta a prueba de alteracion que proporciona liberacion inmediata del farmaco
|
WO2013038268A1
(en)
*
|
2011-09-16 |
2013-03-21 |
Purdue Pharma L.P. |
Tamper resistant immediate release formulations
|
FR2983409B1
(fr)
*
|
2011-12-06 |
2013-12-27 |
Ethypharm Sa |
Comprime susceptible de lutter contre le detournement par voie injectable
|
EP2819656A1
(de)
|
2012-02-28 |
2015-01-07 |
Grünenthal GmbH |
Fälschungssichere dosierform mit einer pharmazeutisch aktiven verbindung und einem anionischen polymer
|
JP6067100B2
(ja)
|
2012-04-18 |
2017-01-25 |
マリンクロッド エルエルシー |
即放性乱用抑止医薬組成物
|
MX362357B
(es)
|
2012-04-18 |
2019-01-14 |
Gruenenthal Gmbh |
Forma de dosificacion farmaceutica resistente a la adulteracion y resistente a la liberacion inmediata de la dosis.
|
US10064945B2
(en)
|
2012-05-11 |
2018-09-04 |
Gruenenthal Gmbh |
Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
|
CA2877774C
(en)
|
2012-07-12 |
2017-07-18 |
Mallinckrodt Llc |
Extended release, abuse deterrent pharmaceutical compositions
|
EP3446685A1
(de)
|
2012-11-30 |
2019-02-27 |
Acura Pharmaceuticals, Inc. |
Selbstregulierende freisetzung eines pharmazeutischen wirkstoffs
|
KR101840526B1
(ko)
|
2013-02-05 |
2018-03-20 |
퍼듀 퍼머 엘피 |
내변조성 제약 제제
|
WO2014146093A2
(en)
|
2013-03-15 |
2014-09-18 |
Inspirion Delivery Technologies, Llc |
Abuse deterrent compositions and methods of use
|
US10751287B2
(en)
|
2013-03-15 |
2020-08-25 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
JP6255474B2
(ja)
|
2013-03-15 |
2017-12-27 |
マリンクロッド エルエルシー |
機能的割線を有する即時放出用の乱用抑止性固体剤形
|
JP6445537B2
(ja)
|
2013-05-29 |
2018-12-26 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
1個または複数の粒子を含有する改変防止(tamper−resistant)剤形
|
AR096439A1
(es)
|
2013-05-29 |
2015-12-30 |
Gruenenthal Gmbh |
Forma de dosificación resistente al uso indebido que contiene una o más partículas
|
EA032465B1
(ru)
|
2013-07-12 |
2019-05-31 |
Грюненталь Гмбх |
Защищенная от применения не по назначению пероральная фармацевтическая лекарственная форма, содержащая этиленвинилацетатный полимер, и способ ее изготовления
|
WO2015035423A2
(en)
*
|
2013-09-09 |
2015-03-12 |
Nova Southeastern University |
Deterring abuse of pharmaceutical products and alcohol
|
US10777298B2
(en)
|
2013-10-13 |
2020-09-15 |
Nova Southeastern University |
Analyzing immune signaling networks for identification of therapeutic targets in complex chronic medical disorders
|
US20150118300A1
(en)
|
2013-10-31 |
2015-04-30 |
Cima Labs Inc. |
Immediate Release Abuse-Deterrent Granulated Dosage Forms
|
EA032013B1
(ru)
*
|
2013-10-31 |
2019-03-29 |
Сайма Лэбс Инк. |
Препятствующие злоупотреблению гранулированные лекарственные формы с немедленным высвобождением
|
AU2014356581C1
(en)
|
2013-11-26 |
2020-05-28 |
Grunenthal Gmbh |
Preparation of a powdery pharmaceutical composition by means of cryo-milling
|
US20160310418A1
(en)
|
2013-12-11 |
2016-10-27 |
Sun Pharmaceutical Industries Limited |
Crush-resistant solid oral dosage form
|
US10105360B2
(en)
|
2013-12-11 |
2018-10-23 |
Develco Pharma Schweiz Ag |
Method and composition for the treatment of opioid induced constipation
|
WO2015086528A1
(de)
|
2013-12-11 |
2015-06-18 |
Develco Pharma Schweiz Ag |
Naloxon-monopräparat und mehrschichttablette
|
US9062063B1
(en)
|
2014-03-21 |
2015-06-23 |
Johnson Matthey Public Limited Company |
Forms of oxymorphone hydrochloride
|
CA2943728C
(en)
|
2014-03-26 |
2020-03-24 |
Sun Pharma Advanced Research Company Ltd. |
Abuse deterrent immediate release biphasic matrix solid dosage form
|
AU2015261060A1
(en)
|
2014-05-12 |
2016-11-03 |
Grunenthal Gmbh |
Tamper resistant immediate release capsule formulation comprising Tapentadol
|
CA2949422A1
(en)
|
2014-05-26 |
2015-12-03 |
Grunenthal Gmbh |
Multiparticles safeguarded against ethanolic dose-dumping
|
ES2963078T3
(es)
|
2014-07-03 |
2024-03-25 |
SpecGx LLC |
Formulaciones de liberación inmediata disuasorias del abuso que comprenden polisacáridos no celulósicos
|
CA2910865C
(en)
|
2014-07-15 |
2016-11-29 |
Isa Odidi |
Compositions and methods for reducing overdose
|
US9132096B1
(en)
|
2014-09-12 |
2015-09-15 |
Alkermes Pharma Ireland Limited |
Abuse resistant pharmaceutical compositions
|
US10729685B2
(en)
|
2014-09-15 |
2020-08-04 |
Ohemo Life Sciences Inc. |
Orally administrable compositions and methods of deterring abuse by intranasal administration
|
US9918979B2
(en)
|
2015-01-29 |
2018-03-20 |
Johnson Matthey Public Limited Company |
Process of preparing low ABUK oxymorphone hydrochloride
|
EP3285745A1
(de)
|
2015-04-24 |
2018-02-28 |
Grünenthal GmbH |
Manipulationssichere darreichungsform mit sofortiger freisetzung und widerstand gegen lösungsmittelextraktion
|
US11103581B2
(en)
|
2015-08-31 |
2021-08-31 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for self-regulated release of active pharmaceutical ingredient
|
JP2018526414A
(ja)
|
2015-09-10 |
2018-09-13 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護
|
WO2017222575A1
(en)
|
2016-06-23 |
2017-12-28 |
Collegium Pharmaceutical, Inc. |
Process of making more stable abuse-deterrent oral formulations
|
CA3112030A1
(en)
|
2018-09-25 |
2020-04-02 |
SpecGx LLC |
Abuse deterrent immediate release capsule dosage forms
|
JP7304691B2
(ja)
*
|
2018-12-06 |
2023-07-07 |
日本ケミファ株式会社 |
ゾピクロン、その光学異性体又はこれらの塩の何れかを有効成分として含有する錠剤
|
GR1009791B
(el)
|
2019-03-26 |
2020-08-03 |
Φαρματεν Α.Β.Ε.Ε. |
Σκευασμα παρατεταμενης αποδεσμευσης που περιλαμβανει ταπενταδολη και μεθοδος παρασκευης αυτου
|
WO2020225773A1
(en)
|
2019-05-07 |
2020-11-12 |
Clexio Biosciences Ltd. |
Abuse-deterrent dosage forms containing esketamine
|